Emerald Advisers’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.21M | Sell |
461,365
-76,884
| -14% | -$1.37M | 0.3% | 102 |
|
|
2025
Q1 | $9.59M | Sell |
538,249
-9,308
| -2% | -$166K | 0.43% | 82 |
|
|
2024
Q4 | $16.3M | Buy |
+547,557
| New | +$16.3M | 0.63% | 67 |
|
|
2021
Q3 | – | Sell |
-2,033
| Closed | -$451K | – | 270 |
|
|
2021
Q2 | $451K | Buy |
+2,033
| New | +$451K | 0.02% | 197 |
|